to develop an easy-to-use

in-vitro diagnostics device

for professionals at the point of care

to rapidly and accurately monitor

specific chronic diseases


Diabetes is a serious life-long health condition that occurs when the amount of glucose (sugar) in the blood is too high because the body can’t use it properly. A major complication of diabetes is the increase in cardiovascular disease including heart attacks and stroke, which can be…


Radisens is developing a next-generation quantitative point-of-care IVD platform –Gemini™ – which has the potential for delivering a finger-stick sample-to-answer solution using long-term room temperature stable test cartridges. The Gemini™ platform is a centrifugal…


The Gemini™ value proposition targets low sample volumes, laboratory-grade performance and lower cost of goods with long-term room temperature storage stability integrating all sample preparation steps, with dry reagents stored on-cartridge, leveraging the many advantages of….


Radisens has a business to business commercial approach with the aim to develop partnerships including technology licensing, development, manufacture and supply with collaborators in decentralised chronic disease monitoring and related markets. . In addition, the Gemini™ platform…